Full Press Release Details
Ultragenyx Announces License of Intellectual Property Related to the Treatment of Huntington's Disease With Triheptanoin.
RARE
Ultragenyx Announces License of Intellectual Property Related to the Treatment of Huntington's Disease With Triheptanoin
Key Takeaway: Ultragenyx Announces License of Intellectual Property Related to the Treatment of Huntington's Disease With Triheptanoin